Join
Live feed
·
PRReleasevia Quantisnow
Rezolute Inc. logo

Rezolute Announces Completion of Enrollment in Phase 3 upLIFT Study of Ersodetug in Tumor Hyperinsulinism

ByQuantisnow·Wall Street's wire, on your screen.
RZLT· Rezolute Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RZLT (Rezolute Inc.) and more on Quantisnow.